{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:02:46Z","timestamp":1790352166480,"version":"4.1.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p><jats:bold>Background and Purpose:<\/jats:bold> Fever in the acute phase of stroke leads to an unfavorable clinical outcome and increased mortality. However, no specific form of effective fever treatment has been established, so far. We analyzed the effectiveness of our in-house standard operating procedure (SOP) of fever treatment.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> This SOP was analyzed for a period of 33 weeks. Patients with cerebral ischemia (ischemic stroke, transient ischemic attack) or cerebral hemorrhage (intracerebral, subarachnoid) and body temperature elevation of \u2265 37.5\u00b0C within the first 6 days after admission were eligible for inclusion in the analysis. The results of SOP group, who's data have been collected prospectively were then compared with a historical control group that had been treated conventionally 1 year earlier in the same period. The data of control group have been collected in retrospect. The primary endpoint was the total duration of the fever for the first 6 days after admission to the stroke unit.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> A total of 130 patients (mean age of 78 \u00b1 12) received 370 antipyretic interventions. Sequential application of paracetamol (<jats:italic>n<\/jats:italic> = 245), metamizole (<jats:italic>n<\/jats:italic> = 53) and calf compress (<jats:italic>n<\/jats:italic> = 15) led to significant reduction in body temperature. In patients who did not respond to these applications, normothermia could be achieved after infusion of the cooled saline solution. Normothermia could be achieved within 120 min in more than 90% of the cases treated by the SOP. The SOP reduced the fever duration in the 6 days significantly, from 12.2 \u00b1 2.7 h [95% confidence interval (CI) for mean] in the control group to 3.9 \u00b1 1.0 h (95% CI) in the SOP group (<jats:italic>p<\/jats:italic> &amp;lt; 0.001). The SOP was rated to be reasonable and effective.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Our in-house SOP is cost-efficient and effective for fever treatment in stroke patients, that can be implemented by local health care professionals.<\/jats:p>","DOI":"10.3389\/fneur.2021.614266","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T08:50:17Z","timestamp":1614847817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of a 4-Step Standard Operating Procedure for the Treatment of Fever in Patients With Acute Stroke"],"prefix":"10.3389","volume":"12","author":[{"given":"Hanna","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter","family":"Hedtmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kollmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"B1","first-page":"476","article-title":"The importance of brain temperature in cerebral injury","volume":"9","author":"Dietrich","year":"1992","journal-title":"J Neurotrauma."},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/2396987318776421","article-title":"Fever worsens outcomes in animal models of ischaemic stroke: a systematic review and meta-analysis","volume":"4","author":"de Jonge","year":"2019","journal-title":"Eur Stroke J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.neuint.2012.02.003","article-title":"Influence of temperature on ischemic brain: basic and clinical principles","volume":"60","author":"Campos","year":"2012","journal-title":"Neurochem Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fneur.2011.00080","article-title":"Therapeutic hypothermia in stroke and traumatic brain injury","volume":"2","author":"Faridar","year":"2011","journal-title":"Front Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.STR.21.9.1318","article-title":"Effects of normothermic versus mild hyperthermic forebrain ischemia in rats","volume":"21","author":"Dietrich","year":"1990","journal-title":"Stroke."},{"key":"B6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0140-6736(96)90008-2","article-title":"Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome","volume":"347","author":"Reith","year":"1996","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/ane.13011","article-title":"Association of survival and hyperthermia after rt-PA for ischemic stroke","volume":"138","author":"Ueno","year":"2018","journal-title":"Acta Neurol Scand."},{"key":"B8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12028-018-0523-y","article-title":"Fever burden and health-related quality of life after intracerebral hemorrhage","volume":"29","author":"Bush","year":"2018","journal-title":"Neurocrit Care."},{"key":"B9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1161\/STROKEAHA.116.015957","article-title":"PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2) Results of a randomized, double-blind placebo-controlled clinical trial","volume":"48","author":"Inger","year":"2017","journal-title":"Stroke."},{"key":"B10","doi-asserted-by":"publisher","first-page":"CD001247","DOI":"10.1002\/14651858.CD001247.pub2","article-title":"Cooling therapy for acute stroke","volume":"21","author":"Den Hertog","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s12028-013-9904-4","article-title":"Safety evaluation of nasopharyngeal cooling (RhinoChill\u00ae) in stroke patients: an observational study","volume":"20","author":"Poli","year":"2014","journal-title":"Neurocrit Care."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11940-017-0437-6","article-title":"Normothermia and stroke","volume":"19","author":"Marehbian","year":"2017","journal-title":"Curr Treat Options Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1159\/000321733","article-title":"Standardized antipyretic treatment in stroke: a pilot study","volume":"31","author":"Kallm\u00fcnzer","year":"2011","journal-title":"Cerebrovasc Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000131083","volume":"25","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/ijs.12309","article-title":"European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage","volume":"9","author":"Steiner","year":"2014","journal-title":"Int J Stroke."},{"key":"B16","unstructured":"ViennaR Foundation for Statistical ComputingR: A Language and Environment for Statistical Computing2018"},{"key":"B17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/biomet\/34.1-2.28","article-title":"The generalization of 'student's' problem when several different population variances are involved","volume":"34","author":"Welch","year":"1947","journal-title":"Biometrika."},{"key":"B18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S1474-4422(09)70051-1","article-title":"The paracetamol (acetaminophen) in stroke (PAIS) trial: a randomized, placebo-controlled, phase III trial","volume":"8","author":"den Hertog","year":"2009","journal-title":"Lancet Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2261-5-24","article-title":"PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial [ISCRTN 74418480]","volume":"5","author":"van Breda","year":"2005","journal-title":"BMC Cardiovasc Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2261-8-29","article-title":"Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial","volume":"8","author":"den Hertog","year":"2008","journal-title":"BMC Cardiovasc Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/ijs.12053","article-title":"Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5\u00b0C or above","volume":"10","author":"de Ridder","year":"2015","journal-title":"Int J Stroke."},{"key":"B22","doi-asserted-by":"publisher","first-page":"768","DOI":"10.7326\/M15-1150","article-title":"Accuracy of peripheral thermometers for estimating temperature: a systematic review and meta-analysis","volume":"163","author":"Niven","year":"2015","journal-title":"Ann Intern Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/STROKEAHA.107.499533","article-title":"Effects of prophylactic antibiotic therapy with mezlocillin plus sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS)","volume":"39","author":"Schwarz","year":"2008","journal-title":"Stroke."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.614266\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T08:50:38Z","timestamp":1614847838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.614266\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":23,"alternative-id":["10.3389\/fneur.2021.614266"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.614266","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"article-number":"614266"}}